The synergistic effects of low-dose irinotecan and TRAIL on TRAIL-resistant HT-29 colon carcinoma in vitro and in vivo.
暂无分享,去创建一个
Ying Huang | C. Yi | Hong Zhu | Fen Zhao | S. Yu | Jianping He | L. Deng | S. Yu | Li-Cong Deng | Shuijing Yu
暂无分享,去创建一个
Ying Huang | C. Yi | Hong Zhu | Fen Zhao | S. Yu | Jianping He | L. Deng | S. Yu | Li-Cong Deng | Shuijing Yu